April 16, 2025 Nvidia’s $5.5B AI Chip Crunch and ASML’s Tariff Jitters
April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency
March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer
February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
ImmunoGen (IMGN) Stock Forecast for 2025, 2026, 2027. Sell or Buy?
Updated: May 16, 2025 (01:43)
Sector: HealthcareThe share price of ImmunoGen, Inc. (IMGN) now
Are you interested in ImmunoGen, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the ImmunoGen stock price in 2025, 2026, 2027. How much will one ImmunoGen share be worth in 2025 - 2027?
When should I take profit in ImmunoGen stock? When should I record a loss on ImmunoGen stock? What are analysts' forecasts for ImmunoGen stock? What is the future of ImmunoGen stock? We forecast ImmunoGen stock performance using neural networks based on historical data on ImmunoGen stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
ImmunoGen stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for ImmunoGen shares. This happens once a day.
Historical and forecast chart of ImmunoGen stock
The chart below shows the historical price of ImmunoGen stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the ImmunoGen stock price can be found in the table below.
Long-term forecasts by years.
ImmunoGen, Inc., a clinical-stage biotechnology company, is developing antibody-drug conjugate (ADC) therapies for cancer. Its candidate products include mirvetuximab soravtansine, an alpha-folate receptor-targeted ADC that is in phase III clinical trials for the treatment of platinum-resistant ovarian cancer; and IMGN632, an ADC targeting CD123, which is in phase I clinical trials for the treatment of AML and blast plasmacytoid dendritic cell neoplasms.
ImmunoGen daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May 17 | 31.11 | 30.91 | 31.17 | 0.83 |
| May 18 | 31.14 | 30.97 | 31.24 | 0.86 |
| May 19 | 31.21 | 31.00 | 31.28 | 0.89 |
| May 20 | 31.22 | 31.05 | 31.37 | 1.05 |
| May 21 | 31.47 | 31.34 | 31.71 | 1.18 |
| May 22 | 31.33 | 31.11 | 31.52 | 1.31 |
| May 23 | 31.30 | 31.12 | 31.52 | 1.31 |
| May 24 | 31.37 | 31.24 | 31.46 | 0.70 |
| May 25 | 31.50 | 31.44 | 31.67 | 0.75 |
| May 26 | 31.47 | 31.38 | 31.65 | 0.86 |
| May 27 | 31.47 | 31.30 | 31.69 | 1.27 |
| May 28 | 31.43 | 31.35 | 31.63 | 0.88 |
| May 29 | 31.58 | 31.34 | 31.82 | 1.52 |
| May 30 | 31.48 | 31.33 | 31.60 | 0.85 |
| May 31 | 31.43 | 31.28 | 31.60 | 1.05 |
| Jun 01 | 31.72 | 31.54 | 31.86 | 1.02 |
| Jun 02 | 31.66 | 31.47 | 31.77 | 0.95 |
| Jun 03 | 31.97 | 31.74 | 32.10 | 1.13 |
| Jun 04 | 31.93 | 31.86 | 32.00 | 0.44 |
| Jun 05 | 31.69 | 31.58 | 31.82 | 0.77 |
| Jun 06 | 31.56 | 31.33 | 31.63 | 0.94 |
| Jun 07 | 31.26 | 31.14 | 31.47 | 1.05 |
| Jun 08 | 31.49 | 31.24 | 31.72 | 1.53 |
| Jun 09 | 31.34 | 31.26 | 31.57 | 1.00 |
| Jun 10 | 31.40 | 31.28 | 31.62 | 1.08 |
| Jun 11 | 31.63 | 31.45 | 31.82 | 1.17 |
| Jun 12 | 31.71 | 31.57 | 31.83 | 0.82 |
| Jun 13 | 31.64 | 31.44 | 31.81 | 1.15 |
| Jun 14 | 31.66 | 31.44 | 31.87 | 1.37 |
| Jun 15 | 31.39 | 31.23 | 31.49 | 0.82 |
ImmunoGen Daily Price Targets
ImmunoGen Stock Forecast 05-17-2025.
Forecast target price for 05-17-2025: $31.11.
Negative dynamics for ImmunoGen shares will prevail with possible volatility of 0.818%.
Pessimistic target level: 30.91
Optimistic target level: 31.17
ImmunoGen Stock Forecast 05-18-2025.
Forecast target price for 05-18-2025: $31.14.
Positive dynamics for ImmunoGen shares will prevail with possible volatility of 0.857%.
Pessimistic target level: 30.97
Optimistic target level: 31.24
ImmunoGen Stock Forecast 05-19-2025.
Forecast target price for 05-19-2025: $31.21.
Positive dynamics for ImmunoGen shares will prevail with possible volatility of 0.878%.
Pessimistic target level: 31.00
Optimistic target level: 31.28
ImmunoGen Stock Forecast 05-20-2025.
Forecast target price for 05-20-2025: $31.22.
Positive dynamics for ImmunoGen shares will prevail with possible volatility of 1.035%.
Pessimistic target level: 31.05
Optimistic target level: 31.37
ImmunoGen Stock Forecast 05-21-2025.
Forecast target price for 05-21-2025: $31.47.
Positive dynamics for ImmunoGen shares will prevail with possible volatility of 1.171%.
Pessimistic target level: 31.34
Optimistic target level: 31.71
ImmunoGen Stock Forecast 05-22-2025.
Forecast target price for 05-22-2025: $31.33.
Negative dynamics for ImmunoGen shares will prevail with possible volatility of 1.293%.
Pessimistic target level: 31.11
Optimistic target level: 31.52
IMGN (IMGN) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jun. | 31.41 | 22.10 | 36.24 | 39.02 |
| Jul. | 34.99 | 28.41 | 42.57 | 33.26 |
| Aug. | 37.18 | 25.31 | 51.81 | 51.14 |
| Sep. | 24.68 | 13.57 | 29.88 | 54.60 |
| Oct. | 16.80 | 14.89 | 24.27 | 38.67 |
| Nov. | 25.04 | 22.18 | 31.17 | 28.84 |
| Dec. | 19.33 | 14.92 | 28.14 | 46.98 |
ImmunoGen forecast for this year
ImmunoGen Stock Prediction for Jun 2025
An uptrend is forecast for this month with an optimal target price of $31.408. Pessimistic: $22.10. Optimistic: $36.24
ImmunoGen Stock Prediction for Jul 2025
An uptrend is forecast for this month with an optimal target price of $34.9885. Pessimistic: $28.41. Optimistic: $42.57
ImmunoGen Stock Prediction for Aug 2025
An uptrend is forecast for this month with an optimal target price of $37.1823. Pessimistic: $25.31. Optimistic: $51.81
ImmunoGen Stock Prediction for Sep 2025
An downtrend is forecast for this month with an optimal target price of $24.6779. Pessimistic: $13.57. Optimistic: $29.88
ImmunoGen Stock Prediction for Oct 2025
An downtrend is forecast for this month with an optimal target price of $16.8007. Pessimistic: $14.89. Optimistic: $24.27
ImmunoGen Stock Prediction for Nov 2025
An uptrend is forecast for this month with an optimal target price of $25.0364. Pessimistic: $22.18. Optimistic: $31.17
ImmunoGen Stock Prediction for Dec 2025
An downtrend is forecast for this month with an optimal target price of $19.3281. Pessimistic: $14.92. Optimistic: $28.14
ImmunoGen (IMGN) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 15.69 | 10.06 | 19.99 | 49.68 |
| Feb | 17.75 | 10.77 | 22.00 | 51.05 |
| Mar | 13.30 | 11.40 | 16.18 | 29.52 |
| Apr | 11.63 | 9.71 | 15.54 | 37.54 |
| May | 14.68 | 8.57 | 16.69 | 48.64 |
| Jun | 22.13 | 12.16 | 31.08 | 60.87 |
| Jul | 19.73 | 14.89 | 22.99 | 35.22 |
| Aug | 18.61 | 15.85 | 24.55 | 35.43 |
| Sep | 26.24 | 17.87 | 36.11 | 50.53 |
| Oct | 22.05 | 17.78 | 30.85 | 42.37 |
| Nov | 20.42 | 17.63 | 27.17 | 35.13 |
| Dec | 18.67 | 15.91 | 22.29 | 28.65 |
ImmunoGen (IMGN) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 10.05 | 7.87 | 13.72 | 42.60 |
| Feb | 4.44 | 3.48 | 5.37 | 35.30 |
| Mar | 4.08 | 3.62 | 4.92 | 26.49 |
| Apr | 5.13 | 3.64 | 6.56 | 44.56 |
| May | 5.66 | 3.92 | 7.88 | 50.32 |
| Jun | 5.88 | 5.01 | 8.06 | 37.85 |
| Jul | 7.06 | 3.88 | 9.67 | 59.89 |
| Aug | 5.45 | 2.99 | 6.53 | 54.17 |
| Sep | 2.50 | 1.56 | 3.45 | 54.86 |
| Oct | 2.07 | 1.21 | 2.86 | 57.75 |
| Nov | 1.72 | 1.30 | 2.47 | 47.54 |
| Dec | 0.92 | 0.53 | 1.35 | 60.68 |
ImmunoGen information and performance
N/A
Market capitalization of the ImmunoGen, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of IMGN shares in the company outstanding by the market price of one share.
EBITDA of ImmunoGen is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
FAQ (Frequently Asked Questions about ImmunoGen Stock)
Should I Buy ImmunoGen Shares in 2025 year?
Does ImmunoGen pay dividends?
Which economic sector do ImmunoGen's shares belong to?
Which other securities belong to the same sector as ImmunoGen's shares?
Related stocks from Healthcare sector
